Developer of novel therapeutics designed for the treatment of age-related diseases. The company's novel molecules can activate a critical endogenous immune surveillance mechanism to selectively remove senescent cells, enabling healthcare providers to treat several classes of age-related diseases.

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Corporate Profile Minimize An organization, like human being, is a dynamic and restless entity, which shall be in perpetual motion to improve and challenge the environment in which it exists. But unlike a human being an organization by its wisdom and innovation can retain eternal youth. Gene-Tech Laboratories is a Bio-pharmaceutical company dealing high tech genetically engineered products. The idea of establishing this company is to create new business concepts that promote high tech genetically engineered products with quality and economy and help the ailing human beings by providing advance and more effective therapeutic solution. As a company, we are passionate about improving the lives for people with severe, life-threatening and often rare diseases. Our commitment goes beyond bringing innovative new medicines primarily in specialty-driven markets including Gastroenterology, Oncology, Pediatrics, Cardiovascular, hospital and acute care medicines. Gene-Tech Laboratories relying on talented and dedicated employees, following a strategic vision builds close relationships with the medical community and flexible collaborative partnerships with other pharmaceutical companies. Gene-Tech Laboratories is redefining the standards for success in pursuing opportunities in the health care industry. We work with patient organizations to support patient education programs. Fully integrated resources in scientific and technical operations, coupled with a fully aligned sales force, enable us to move quickly to capitalize on scientific advances and bring innovative medicines to market. These strategic competencies, combined with dynamic executive leadership, strategic discipline and financial strength, have established Gene-Tech Laboratories as a leading specialty Bio-pharmaceutical company in Pakistan. We pride in our ability to in all adversities and come out as a more vigorous organization.

We are a telomere science dedicated company located in ON, Canada. We offer TA-65 supplements and cosmetic creams through our website as well as health practitioner clinics.

Defytimer

Our success in creating cutting-edge natural health and beauty products continues to grow and includes Telomere Health, a formulation based on the very latest advancements in anti-aging science. Often referred to as 'the fountain of youth', telomerase is an enzyme responsible for constructing and maintaining the telomere. To see our full range of scientifically formulated natural health and beauty products visit our products page.

The company primarily operates in the Media and Information Services (B2B) industry. Longevity Alliance Georgia is headquartered in Tbilisi, Georgia.

BioViva is committed to creating regenerative medicine to alleviate diseases caused by cellular degeneration and genetic disorders. It focuses on aging, as this is the common root of most major diseases. They bring these treatments to the clinic for both compassionate and consensual use and to change how they treat disease in the future. The company was founded in 2015 and is headquartered in Bainbridge Island, Washington.

Telomere Therapeutics creates gene therapy based on telomerase gene expression for the treatment of age-related diseases like idiopathic pulmonary fibrosis, aplastic anemia, or dyskeratosis congenita.

Developer of Cellular senescence (senolytic) and Immuno-senescence-based drugs to provide innovative treatments for aging-related diseases. The company offers a unique mechanism of action that includes activating p53 and pro-apoptotic signals, suppressing macrophage M2-polarization, and boosting the expression of immune checkpoint proteins like PD-(L)1, enabling these crucial actions to stop both immunosenescence and cellular senescence at the same time.